Drug Abuse, Major Depressive Disorder, Medications, Relapse
Conditions
Keywords
Major depressive disorder, ketamine, follow up, Antidepressants
Brief summary
Patients who suffer from MDD recieved ketamnie (2014-15) in open study will be addressed and there depression mood will be evaluated using the rating scale that were used in the original research. In addition time of relapse and questions about their medications and drug use will be performed.
Detailed description
Patients who suffer from Major Depressive disorder and are outpatients in our clinic and, received in the years (2014-15) ketamine in open study will be addressed and there depression mood will be evaluated using the rating scale that were used in the original research. In addition time of relapse and questions about their medications and drug use will be performed.
Interventions
OTHERNon
Follow up
Sponsors
Sheba Medical Center
Study design
Observational model
OTHER
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Inclusion criteria
* Patient who participated in ketamine study 1126
Exclusion criteria
* None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mood that will be evaluated using the MADRAS Montgomery-Asberg Depression Rating Scale. | 6 months |
Countries
Israel
Outcome results
None listed